Figure 2. Cumulative mortality for patients in care and lost to clinic.

Crude (grey) and standardized (black) survival curves compare mortality between patients continuously retained in care at CNICS sites (solid lines) and patients lost to clinic (dotted lines) among 7183 patients who initiated antiretroviral therapy between January 1, 1998 and December 31, 2009 and survived for at least one year at 8 US clinical sites, followed for death up for 5 years.